Westfield Capital Management’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-25,250
| Closed | -$898K | – | 249 |
|
|
2019
Q2 | $898K | Hold |
25,250
| – | – | 0.01% | 224 |
|
|
2019
Q1 | $848K | Hold |
25,250
| – | – | 0.01% | 226 |
|
|
2018
Q4 | $830K | Sell |
25,250
-240,011
| -90% | -$7.89M | 0.01% | 226 |
|
|
2018
Q3 | $16.2M | Sell |
265,261
-455,795
| -63% | -$27.8M | 0.11% | 187 |
|
|
2018
Q2 | $35.2M | Sell |
721,056
-292,876
| -29% | -$14.3M | 0.26% | 130 |
|
|
2018
Q1 | $108M | Sell |
1,013,932
-1,279,249
| -56% | -$136M | 0.83% | 28 |
|
|
2017
Q4 | $137M | Sell |
2,293,181
-1,339,238
| -37% | -$80M | 1.05% | 14 |
|
|
2017
Q3 | $87.2M | Sell |
3,632,419
-141,564
| -4% | -$3.4M | 0.67% | 48 |
|
|
2017
Q2 | $73.8M | Sell |
3,773,983
-256,556
| -6% | -$5.02M | 0.63% | 53 |
|
|
2017
Q1 | $94.6M | Sell |
4,030,539
-158,238
| -4% | -$3.71M | 0.81% | 33 |
|
|
2016
Q4 | $51.4M | Buy |
4,188,777
+1,527,673
| +57% | +$18.7M | 0.45% | 86 |
|
|
2016
Q3 | $45.7M | Buy |
2,661,104
+1,449,054
| +120% | +$24.9M | 0.37% | 92 |
|
|
2016
Q2 | $17.2M | Buy |
+1,212,050
| New | +$17.2M | 0.14% | 172 |
|